Format

Send to

Choose Destination
Cancer Prev Res (Phila). 2017 Nov;10(11):651-659. doi: 10.1158/1940-6207.CAPR-17-0098. Epub 2017 Sep 6.

Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.

Author information

1
The Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts. aspira@bu.edu mlenburg@bu.edu anapavel@bu.edu.
2
Section of Computational Biomedicine, Boston University School of Medicine, Boston, Massachusetts.
3
The Graduate Program in Bioinformatics, Boston University, Boston, Massachusetts.
4
University of California Los Angeles, Los Angeles, California.
5
Veracyte, South San Francisco, California.

Abstract

We have previously shown that gene expression alterations in normal-appearing bronchial epithelial cells can serve as a lung cancer detection biomarker in smokers. Given that miRNAs regulate airway gene expression responses to smoking, we evaluated whether miRNA expression is also altered in the bronchial epithelium of smokers with lung cancer. Using epithelial brushings from the mainstem bronchus of patients undergoing bronchoscopy for suspected lung cancer (as part of the AEGIS-1/2 clinical trials), we profiled miRNA expression via small-RNA sequencing from 347 current and former smokers for which gene expression data were also available. Patients were followed for one year postbronchoscopy until a final diagnosis of lung cancer (n = 194) or benign disease (n = 153) was made. Following removal of 6 low-quality samples, we used 138 patients (AEGIS-1) as a discovery set to identify four miRNAs (miR-146a-5p, miR-324-5p, miR-223-3p, and miR-223-5p) that were downregulated in the bronchial airway of lung cancer patients (ANOVA P < 0.002, FDR < 0.2). The expression of these miRNAs is significantly more negatively correlated with the expression of their mRNA targets than with the expression of other nontarget genes (K-S P < 0.05). Furthermore, these mRNA targets are enriched among genes whose expression is elevated in cancer patients (GSEA FDR < 0.001). Finally, we found that the addition of miR-146a-5p to an existing mRNA biomarker for lung cancer significantly improves its performance (AUC) in the 203 samples (AEGIS-1/2) serving an independent test set (DeLong P < 0.05). Our findings suggest that there are miRNAs whose expression is altered in the cytologically normal bronchial epithelium of smokers with lung cancer, and that they may regulate cancer-associated gene expression differences. Cancer Prev Res; 10(11); 651-9. ©2017 AACR.

PMID:
28877936
DOI:
10.1158/1940-6207.CAPR-17-0098
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center